Literature DB >> 16639007

Effects of latrunculin-B on outflow facility and trabecular meshwork structure in human eyes.

C Ross Ethier1, A Thomas Read, Darren W-H Chan.   

Abstract

PURPOSE: To determine the effect of the F-actin-disrupting agent latrunculin-B on aqueous outflow facility and trabecular meshwork architecture in human eyes.
METHODS: After baseline facility measurement in human eye bank eyes (n = 9 pairs), one eye of each pair received anterior chamber exchange and continued perfusion with medium containing 1 microM latrunculin-B. Contralateral eyes were treated in a similar manner with vehicle. Eyes were fixed by anterior chamber exchange and perfusion with universal fixative at 8 mm Hg (corresponding to a physiologic pressure of 15 mm Hg in vivo), and outflow pathway tissues were examined by transmission and scanning electron microscopy.
RESULTS: Perfusion of eyes with 1 microM latrunculin-B caused a continuous and ongoing increase in outflow facility, resulting in a net facility difference of 64% 2 hours after drug administration (P < 0.006). Transmission electron microscopy showed subtle and focal detachment of the inner wall of Schlemm's canal, rarefaction of the juxtacanalicular tissue (JCT), and cell-cell and cell-matrix detachment. Scanning electron microscopy showed collapsed vacuoles in the inner wall of Schlemm's canal and a marked increase in the number and size of border (paracellular) pores in the inner wall.
CONCLUSIONS: Latrunculin-B increases outflow facility in postmortem human eyes. The mechanism of facility increase is most likely due to loss of mechanical integrity of the trabecular meshwork as a consequence of reduction in cell-cell and cell-matrix adhesion. The facility increase and the extent of inner wall separation from the JCT that we observed were both qualitatively similar to that reported in living monkey eyes, but the magnitude of the facility increase and morphologic changes were much less than in the living monkey. This supports the idea that inner wall separation from the JCT may modulate outflow facility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16639007     DOI: 10.1167/iovs.05-0327

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  44 in total

1.  Substratum compliance regulates human trabecular meshwork cell behaviors and response to latrunculin B.

Authors:  Joshua A Wood; Clayton T McKee; Sara M Thomasy; Marion E Fischer; Nihar M Shah; Christopher J Murphy; Paul Russell
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-02       Impact factor: 4.799

2.  Aqueous humor outflow: what do we know? Where will it lead us?

Authors:  Michael P Fautsch; Douglas H Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-10       Impact factor: 4.799

3.  Effects of Y27632 on aqueous humor outflow facility with changes in hydrodynamic pattern and morphology in human eyes.

Authors:  Chen-Yuan Charlie Yang; Ye Liu; Zhaozeng Lu; Ruiyi Ren; Haiyan Gong
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-28       Impact factor: 4.799

4.  Colocalization of outflow segmentation and pores along the inner wall of Schlemm's canal.

Authors:  Sietse T Braakman; A Thomas Read; Darren W-H Chan; C Ross Ethier; Darryl R Overby
Journal:  Exp Eye Res       Date:  2014-11-13       Impact factor: 3.467

Review 5.  Exciting directions in glaucoma.

Authors:  Carol A Rasmussen; Paul L Kaufman
Journal:  Can J Ophthalmol       Date:  2014-12       Impact factor: 1.882

6.  Effects of chemical inhibition of N-WASP, a critical regulator of actin polymerization on aqueous humor outflow through the conventional pathway.

Authors:  Toshihiro Inoue; Padmanabhan P Pattabiraman; David L Epstein; P Vasantha Rao
Journal:  Exp Eye Res       Date:  2009-12-02       Impact factor: 3.467

7.  The mechanism of increasing outflow facility by rho-kinase inhibition with Y-27632 in bovine eyes.

Authors:  Zhaozeng Lu; Darryl R Overby; Patrick A Scott; Thomas F Freddo; Haiyan Gong
Journal:  Exp Eye Res       Date:  2007-11-05       Impact factor: 3.467

8.  Directed therapy for exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Open Ophthalmol J       Date:  2009-09-17

9.  Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Middle East Afr J Ophthalmol       Date:  2009-01

10.  Dexamethasone disrupts intercellular junction formation and cytoskeleton organization in human trabecular meshwork cells.

Authors:  Ye Hong Zhuo; Yuan He; Kar Wah Leung; Fei Hou; Yi Qing Li; Fang Chai; Jian Ge
Journal:  Mol Vis       Date:  2010-01-16       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.